Trials / Completed
CompletedNCT02950467
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Joshua Woolley · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).
Detailed description
This study is an open-label mixed-methods pilot study of an individual oral psilocybin drug session combined with ten sessions of an evidence-based, manualized brief group psychotherapy for existential distress in palliative care patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Psilocybin | One individual oral psilocybin treatment session |
| BEHAVIORAL | Modified brief Supportive Expressive Group Therapy | Ten sessions of twice-weekly manualized group therapy |
Timeline
- Start date
- 2018-01-05
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2016-11-01
- Last updated
- 2021-01-07
- Results posted
- 2021-01-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02950467. Inclusion in this directory is not an endorsement.